Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026)
Planet 13 Holdings (PLNH) reported Non-Current Deferred Tax Liability of $663317.0 for Q1 2026, down 46.15% year-over-year from $1.2 million in Q1 2025, and up 30.87% quarter-over-quarter from $506836.0 in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $663317.0 in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $663317.0, down 46.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $663317.0 (down 46.15% YoY), and the FY2025 annual result was $506836.0, down 69.87% from the prior year.
- Non-Current Deferred Tax Liability grew to $663317.0 in Q1 2026 per PLNH's latest filing, from $506836.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $3.9 million in Q3 2024 and troughed at $11504.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of $1.5 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability jumped 165.91% in 2024, then tumbled 99.71% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $1.5 million in 2022, then jumped by 136.12% to $3.5 million in 2023, then plunged by 52.1% to $1.7 million in 2024, then plunged by 69.87% to $506836.0 in 2025, then jumped by 30.87% to $663317.0 in 2026.
- Business Quant data shows PLNH's Non-Current Deferred Tax Liability at $663317.0 in Q1 2026, $506836.0 in Q4 2025, and $11504.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 663,317.00 |
| Mar 31, 2026 | 663,317.00 |
| Dec 31, 2025 | 506,836.00 |
| Dec 31, 2025 | 506,836.00 |
| Sep 30, 2025 | 11,504.00 |
| Sep 30, 2025 | 11,504.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Dec 31, 2023 | 3.51 Mn |